Sphere Bio Limited

Sphere Bio Ltd, based in Cambridge, UK, is a small, active company established fifteen years ago in 2010. With 41 employees and £12,362,811 in assets, it operates from a real address and is managed by eight directors, although no owners are officially listed. The company regularly imports and exports optical and medical tools and devices, with 51 months of import activity and 132 months of export activity recorded.

Sphere Bio's core business revolves around cell analysis and isolation technologies, as evidenced by its website. It offers platforms like CytoMine Chroma and CytoMine, alongside various assay kits, consumables, and reagents. The company caters to biologics discovery and development, cell engineering, synthetic biology, and cell therapy sectors. The website highlights its expertise in single-cell analysis, multiplexing, and picodroplet technology, positioning itself as a provider of innovative solutions for researchers and developers. It also features a knowledge hub with webinars, application notes, and case studies, demonstrating a commitment to customer support and education.

Financially, Sphere Bio Ltd exhibits some concerning trends. Cash reserves have taken a significant hit, declining by 52% to £7,600,000. Bank borrowings have increased, rising to £18,000, while net assets have dropped 52% to -£31,000,000. Creditors have also increased, suggesting a growing reliance on external financing. The company’s average number of employees has increased by 56% to 64, which could be a sign of growth, but it also adds to operational costs. Despite these challenges, the company’s fixed assets have increased by 120%, potentially reflecting investments in new equipment or infrastructure. The deferred tax expense credit has also increased by 93%, which may indicate changes in tax planning strategies.

It's worth noting that the company's financial statements are unaudited, which means they haven't been independently verified. The increase in future minimum lease payments by 640% is a significant factor to consider, potentially reflecting expansion plans or renegotiated lease terms. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows for agility, but the substantial equity decline and increased debt warrant close monitoring.

Registered in England/Wales under the registration number 07167872, with a registered address at CB21 6AL, England, Cambridge, Building One Granta Centre, Granta Park, Great Abington.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.